Indian J Med Sci About us | Subscription  |  Top cited articles | Contact Us | Feedback | Login   
Print this page Email this page   Small font size Default font size Increase font size 
 Users Online : 144
Home Current Issue Ahead of print Back Issues  Instructions Search e-Alerts
  Navigate here 
  Search
 
 ¤  Next article
 ¤  Previous article 
 ¤  Table of Contents
  
 Resource links
 ¤   Similar in PUBMED
 ¤  Search Pubmed for
 ¤  Search in Google Scholar for
 ¤   [PDF Not available] *
 ¤   Citation Manager
 ¤   Access Statistics
 ¤   Reader Comments
 ¤   Email Alert *
 ¤   Add to My List *
* Registration required (free)  


  In this article
 ¤  Materials and Me...
 ¤  Results
 ¤  Discussion
 ¤  Summary
 ¤  References
 ¤  Article Tables

 Article Access Statistics
    Viewed1470    
    Printed45    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
ORIGINAL CONTRIBUTION
Year : 2000  |  Volume : 54  |  Issue : 9  |  Page : 384-387
 

Effect of single dose of prednisolone on hospitalisation in patients of acute bronchial asthma


1 Department of Pharmacology, Indira Gandhi Medical College, Nagpur 18, India
2 Department of Paediatrics, Indira Gandhi Medical College, Nagpur 18, India

Correspondence Address:
S M Mahakalkar
Department of Pharmacology, Indira Gandhi Medical College, Nagpur 18
India
Login to access the Email id


PMID: 11966062

Get Permissions



How to cite this article:
Mahakalkar S M, Tibdewal S, Khobragade B P. Effect of single dose of prednisolone on hospitalisation in patients of acute bronchial asthma. Indian J Med Sci 2000;54:384-7

How to cite this URL:
Mahakalkar S M, Tibdewal S, Khobragade B P. Effect of single dose of prednisolone on hospitalisation in patients of acute bronchial asthma. Indian J Med Sci [serial online] 2000 [cited 2013 May 22];54:384-7. Available from: http://www.indianjmedsci.org/text.asp?2000/54/9/384/12045


Traditionally, symptomatic con­trol of bronchoconstriction with β2­agonist has been the mainstay of therapy. [1] However, with growing awareness that asthma is an inflammatory condition, the paradigm of asthma medication is shifting to use of anti-inflammatory agents. Glucocorticoids are potent anti-­inflammatory agents available for the treatment of asthma. Their efficacy is related to many factors including a diminution in inflamma­tory cell function and activation, stabilisation of vascular leakage, a decrease in mucus production, and an increase in β-ardrenergic response. [2] Patients of asthma fre­quently require hospitalisation. Despite advances in bronchodila for therapy, the admission rate continues to rise. Various au­thors [3],[4],[5],[6] have reported that stat dose of steroids given to patients of acute bronchial asthma reduces the rate of hospitalisation. There have been studies reporting com­bination of corticosteroids with bronchodilator as more beneficial than bronchodilators alone. The present study was undertaken to assess the effect of stat dose of oral prednisolone on rate of hospitalisation in patients of acute bronchial asthma.


 ¤ Materials and Methods Top


The inclusion criteria required patients (aged 1-65 years) present­ing with history of cough, breath­lessness associated with wheezing and respiratory rate more than 30 breaths/minute. Patients who had chronic respiratory illness like bronchiectesis, pulmonary tuber­culosis or history suggestive of foreign body aspiration, pregnant patients and patients taking regu­lar bronchodilator drugs for chro­nic asthma were excluded from the study.

A total of 259 patients attending casualty or out patient department at Indira Gandhi Medical College and Hospital for acute exacerba­tion of bronchial asthma over a period of 14 months were assigned in a randomised double blind fashion to receive a stat dose of oral prednisolone (30 mg if age <5 years or 60 mg if age >5 years) or equivalent placebo. [3],[6] after base line investigations. All pa­tients were then given nebulised salbutamol (0.15 mg 1 Kg/dose) in 2 m/l normal saline for 5-10 minutes. Same treatment was repeated after 20 minutes for 2 more doses if patients did not res­pond. [1] No other medication was allowed during the study. All clini­cal parameters pulse, respiratory rate, blood pressure, wheezing and retraction and peak expiratory flow rate were repeated at one and four hours of therapy. After total obser­vation period of 4 hours, hospitali­sation if any was noted. The clinical criteria for hospitalisation in­cluded tachypnoea > 30 breaths/ min, tachycardia > 120 beats/min, accessory muscle use, silent chest or feeble respiratory ecort, cyano­sis, bradycardia, hypotension, con­fusion or coma while laboratory criteria were PEFR <60% of per­cent predicted PEFR, PaO 2 < 80 mmHg, PaCO 2 >45 mmHg and O 2 saturation <90%. [7]

All patients gave informed written consent and the study was approv­ed by the ethical committee of the institution. Paired student 't' test for parameteric data and chisquare test for non-parametric data was used for statistical analysis.


 ¤ Results Top


Of the 259 patients of acute bronchial asthma, 135 (52.12%) were males and 124 (47.78%) were females [Table 1] shows the effect of single dose of oral prednisolone after reexamina­tion at 4 hours of therapy. Though, clinically there was improvement in patients of both the groups, only 37 (26.42%) patients given predni­sclone and 50(42.01%) patients given placebo required hospialisa­tion and further management (p <0.01, x 2 = 7.0007 [Table 1]).


 ¤ Discussion Top


The present study was under­taken to assess the effect of single dose of oral prednisolone along with routine bronchodilators, on rate of hospitalisation in patients of acute bronchial asthma. The re­sults showed that clinical parameters indicative of severity of asthma improved in both the groups. But, the number of pa­tients requiring hospitalisation and further management were significantly (p<0.01) less in predni­solone group compared to placebo group. This suggests that subjec­tive decision of "fitness for dis­charge" significantly favours pre­dnisolone use. Similar observation has been reported. [3],[4]

In acute exacerbation of bron­chial asthma the severity of sym­ptoms and response to therapy de­pends on differential contribution of bronchospasm versus other pathophysiological constituents of inflammation, for example, muco­sal sloughing, bronchial oedema and accumulation of secretions within the airway lumen. Corticosteroids are potent anti-inflamma­tory agents and also are said to restore the bronchial hyperresponsiveness to β-adrenergic agonist. Several mechanisms may be in­volved such as increased agonist binding, decreased receptor turn­over, increased uncoupling bet­ween receptor and adenyl cyclase, decreased extraneuronal uptake and decreaseed catechol . O- me­thyl transferase activity. [8] This sug­gests that combination of drugs which relieves bronchospasm and controls inflammation might be more useful than single drug dur­ing the acute attack of asthma. [9] In the present study also beneficial effects of steroids along with bron­chodilators has been observed and it is concluded that the prompt use of single oral dose of prednisolone can significantly reduce morbidity and need for hospital admission in patients of acute bronchial asthma.


 ¤ Summary Top


The present study was under­taken to assess the effect of stat dose of oral prednisolone on rate of hospitalisation in patients of acute bronchial asthma. 259 patients, aged 1-65 years presenting with acute exacerbation of asthma were randomised in a double blind fashion to receive a stat dose of oral prednisolonev (30 mg if age <5 years; 60mg if age > 5 years) or equivalent placebo. Then, ne­bulbutamol (0.15 mg/kg in 2m/l normal saline) was given to all pa­tients and patients were re-exa­mined after 4 hours to decide about the hospitalisation.

The study revealed that only 37 (26.42%) patients required hospitalisation and further management in prednisolone group compared to 50 (42.01%) patients in placebo group (p<0.01). This suggests that prompt use of single oral dose of prednisolone along with routine bronchodilator therapy can significantly reduce morbidity and need for hospital admission in patients of acute bronchial asthma.

 
 ¤ References Top

1.McFadden ER. Asthma. Harrison's Principles of internal medicine, Volume II, 13th edition, Issel-bacher KJ, Braunwald E, eds Mc Graw Hill Inc., 1994;1167-1172.  Back to cited text no. 1    
2.Lemanske RE, Busse WW. Asthma. JAMA, 1997;278:1855-1873.  Back to cited text no. 2    
3.Storr J, Barry W, Barrel E, Lenney W, Hatcher G. Effects of a single oral dose of prednisolone in acute childhood asthma. Lancet 1987;1: 879-882.  Back to cited text no. 3    
4.Chapman KR, Verbeek PR, White JG, Rebuck AS. Effect of a short course of prednisone in the preven­tion of early relapse after the emergency room treatment of acute asthma. N Engl J Med 1997: 324.788-794.  Back to cited text no. 4    
5.Wolfson DH, Nypaver MM, Blaser M, Hogan A, et al. A controlled trial of methyl prednisolone in the early emergency department treatment of acute asthma in children. Paediatr Emerg Care, 1994;10:335-338.  Back to cited text no. 5    
6.Connet GJ, Warde C, Wooler E, Lezmey W. Prednisolone and sal­butamal in the hospital treatment of acute asthma. Arch Dis Child 1994;70:170-173.  Back to cited text no. 6    
7.Abou Shala N, Maclntyre N. Emer­gent Management of Acute Asthma. Med Clin North America, 1996:80: 677-699.  Back to cited text no. 7    
8.Pauwels R. Effect of corticosteroids on action of sympathomimetics. Bull Eur Physiopathol Respir 1985: 21:53s-55s.  Back to cited text no. 8    
9.Pedersen S, Hansen OR Bude­sonide treatment of moderate and severe asthma in children : a dose - response study. J Allergy Clin Immunol 1995;95:29-33.  Back to cited text no. 9    



 
 
    Tables

  [Table 1]

This article has been cited by
1 The assessment and management of patients with acute asthma
Behbehani, N., FitzGerald, J.M.
International Journal of Tuberculosis and Lung Disease. 2006; 10(4): 356-364
[Pubmed]
2 Broadening the therapeutic options in acute asthma
Fitzgerald JM
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2003; 167 (4): 488-489
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

© 2004 - Indian Journal of Medical Sciences
Published by Medknow
Online since 15th December '04